BioSpace News Archive

The donated swabs help replenish dwindling supplies used for COVID-19 Testing

Rensselaer, NY facility is the first and only facility to receive the top designation from SafeBridge Consultants

More than $2.5 million allocated to 72 regional nonprofits in third round distributions, including many serving high-risk older adult populations

ATAI Life Sciences (“ATAI” or the “Company”), a global biotechnology company builder founded by Christian Angermayer that envisions an end to mental illnesses, today announced the close of a $24 million convertible note financing round

Innovative California company creates coated fabric to replace the non woven goods that are increasingly difficult to find

The Centers for Disease Control and Prevention announced funding for expanding public health staff at state health departments to focus on COVID-19 testing and contact tracing.

New information on COVID-19 emerges every day. Researchers and scientists in Canada and around the world are working hard to better understand the virus, and its impacts on people and communities.

Veracyte, Inc. (Nasdaq: VCYT) and Yale University announced an exclusive licensing agreement to advance the first genomic test for predicting disease progression in patients with idiopathic pulmonary fibrosis (IPF).

The COVID-19 pandemic is causing businesses to take extra precautions for the well-being of employees and customers.

Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, cardiovascular disease, today announced that it has entered into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of 2,162,166 shares of its common stock, at a purchase price of $2.3125